Echinacoside improves hematopoietic function in 5-FU-induced myelosuppression mice

Life Sciences

Volumn 123, Issue , 2015, Pages 86-92

  Wang, Saisai ^a,d   Zheng, Gang ^d   Tian, Shousheng ^b   Zhang, Yan ^b   Shen, Lijuan ^c   Pak, Yongchol ^d   Shen, Yong ^a,d   Qian, Jing ^d  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b Engineering Technology Research Center of Glue of Traditional Medicine Shandong Dongeejiao Co Ltd   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Echinacoside; GM CSF; Hematopoietic; Myelosuppression; PI3K signaling pathway

Indexed keywords

ECHINACOSIDE; FLUOROURACIL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RNA; GLYCOSIDE; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW DEPRESSION; BONE MARROW STROMA CELL; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MEDICAL TECHNOLOGY; MOUSE; NONHUMAN; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW DISEASES; CFU COUNTING; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEMATOPOIESIS; MESENCHYMAL STROMA CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MUS;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; BONE MARROW DISEASES; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROURACIL; GLYCOSIDES; HEMATOPOIESIS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84921940327     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.01.002     Document Type: Article

References (36)

1. E.S.D. Alleva Guide for the care and use of laboratory animals Ethology 103 1997 1072 1073
2. J. Bergh, T. Wiklund, B. Erikstein, E. Lidbrink, H. Lindman, and P. Malmstrom Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study Lancet 356 2000 1384 1391
3. A. Bernstein, L. Forrester, A.D. Reith, P. Dubreuil, and R. Rottapel The murine W/c-kit and steel loci and the control of hematopoiesis Semin. Hematol. 28 1991 138 142
4. P.J. Carey Drug-induced myelosuppression: diagnosis and management Drug Saf. 26 2003 691 706
5. F. Cheung TCM: made in China Nature 480 2011 S82 S83
6. E.H. Choi, H.E. Ok, Y. Yoon, B.A. Magnuson, M.K. Kim, and H.S. Chun Protective effect of anthocyanin-rich extract from bilberry (Vaccinium myrtillus L.) against myelotoxicity induced by 5-fluorouracil BioFactors (Oxf. England) 29 2007 55 65
7. J. Crawford, H. Ozer, R. Stoller, D. Johnson, G. Lyman, and I. Tabbara Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer N. Engl. J. Med. 325 1991 164 170
8. L. Dalby-Brown, H. Barsett, A.K. Landbo, A.S. Meyer, and P. Molgaard Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins J. Agric. Food Chem. 53 2005 9413 9423
9. W.H. de Vos tot Nederveen Cappel, H.J. Meulenbeld, J.H. Kleibeuker, F.M. Nagengast, F.H. Menko, and G. Griffioen Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer Int. J. Cancer 109 2004 468 471
10. L.E. Friberg, and M.O. Karlsson Mechanistic models for myelosuppression Investig. New Drugs 21 2003 183 194
11. X. Geng, X. Tian, P. Tu, and X. Pu Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease Eur. J. Pharmacol. 564 2007 66 74
12. J.Y. Han, R.Y. Goh, S.Y. Seo, T.H. Hwang, H.C. Kwon, and S.H. Kim Cotransplantation of cord blood hematopoietic stem cells and culture-expanded and GM-CSF -/SCF-transfected mesenchymal stem cells in SCID mice J. Korean Med. Sci. 22 2007 242 247
13. E.L. Herzog, L. Chai, and D.S. Krause Plasticity of marrow-derived stem cells Blood 102 2003 3483 3493
14. C. Jia, H. Shi, W. Jin, K. Zhang, Y. Jiang, and M. Zhao Metabolism of echinacoside, a good antioxidant, in rats: isolation and identification of its biliary metabolites Drug Metab. Dispos. 37 2009 431 438
15. S. Kojima, K. Takaba, N. Kimoto, T. Takeda, M. Kakuni, and M. Mizutani Protective effects of glutathione on 5-fluorouracil-induced myelosuppression in mice Arch. Toxicol. 77 2003 285 290
16. R. Kuang, Y. Sun, W. Yuan, L. Lei, and X. Zheng Protective effects of echinacoside, one of the phenylethanoid glycosides, on H(2)O(2)-induced cytotoxicity in PC12 cells Planta Med. 75 2009 1499 1504
17. J.C. Laurenz, M. Hadjisavas, G.W. Chovanic, and F.W. Bazer Myelosuppression in the pig (Sus scrofa): uteroferrin reduces the myelosuppressive effects of 5-fluorouracil in young pigs Comp. Biochem. Physiol. A Physiol. 116 1997 369 377
18. F. Li, Y. Yang, P. Zhu, W. Chen, D. Qi, and X. Shi Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells Fitoterapia 83 2012 1443 1450
19. A. Lindner, D. Santilli, J. Hodgett, and C. Nerlinger Effects of 5-fluorouracil on the hematopoietic system of the mouse Cancer Res. 20 1960 497 502
20. D.B. Longley, D.P. Harkin, and P.G. Johnston 5-fluorouracil: mechanisms of action and clinical strategies Nat. Rev. Cancer 3 2003 330 338
21. B.R. Luce, J.W. Singer, J.M. Weschler, C.D. Buckner, S.H. Sheingold, and K. Shannon-Dorcy Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trial PharmacoEconomics 6 1994 42 48
22. M. Malet-Martino, and R. Martino Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review Oncologist 7 2002 288 323
23. S. Mishima, A. Nagai, S. Abdullah, C. Matsuda, T. Taketani, and S. Kumakura Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent Eur. J. Haematol. 84 2010 538 546
24. M. Mostafa, N. Nahar, M. Mosihuzzaman, T. Makhmoor, M.I. Choudhary, and A.U. Rahman Free radical scavenging phenylethanoid glycosides from Leucas indica Linn Nat. Prod. Res. 21 2007 354 361
25. S. Numazawa, K. Sugihara, S. Miyake, H. Tomiyama, A. Hida, and M. Hatsuno Possible involvement of oxidative stress in 5-fluorouracil-mediated myelosuppression in mice Basic Clin. Pharmacol. Toxicol. 108 2011 40 45
26. D.J. Prockop Marrow stromal cells as stem cells for continual renewal of nonhematopoietic tissues and as potential vectors for gene therapy J. Cell. Biochem. 1998 284 285
27. B.D. Sloley, L.J. Urichuk, C. Tywin, R.T. Coutts, P.K. Pang, and J.J. Shan Comparison of chemical components and antioxidants capacity of different Echinacea species J. Pharm. Pharmacol. 53 2001 849 857
28. C. Twelves, A. Wong, M.P. Nowacki, M. Abt, H. Burris III, and A. Carrato Capecitabine as adjuvant treatment for stage III colon cancer N. Engl. J. Med. 352 2005 2696 2704
29. M. Valtieri, and A. Sorrentino The mesenchymal stromal cell contribution to homeostasis J. Cell. Physiol. 217 2008 296 300
30. L. van de Laar, P.J. Coffer, and A.M. Woltman Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy Blood 119 2012 3383 3393
31. J.M.B.K. Worlein, M. Bloomsmith, K. Coleman, and T.L. Koban The eighth edition of the Guide for the Care and use of Laboratory Animals (2011); implications for behavioral management Am. J. Primatol. 73 2011 98
32. Y. Wu, L. Li, T. Wen, and Y.Q. Li Protective effects of echinacoside on carbon tetrachloride-induced hepatotoxicity in rats Toxicology 232 2007 50 56
33. S.F. Xu, L.M. Yu, Z.H. Fan, Q. Wu, Y. Yuan, and Y. Wei Improvement of ginsenoside Rg1 on hematopoietic function in cyclophosphamide-induced myelosuppression mice Eur. J. Pharmacol. 695 2012 7 12
34. Y. Zhang, J. Xing, T. Ai, T. Wen, L. Guan, and J. Zhao Protection of echinacoside against acute lung injury caused by oleic acid in rats Free Radic. Res. 41 2007 798 805
35. A.B. Zhao, B. Yu, X.L. Wu, K.J. Cao, E.Q. Li, and Q.M. Li Protective effects on myelosuppression mice treated by three different classic Chinese medicine formulae Pharmacogn. Mag. 7 2011 133 140
36. M. Zhu, C. Lu, and W. Li Transient exposure to echinacoside is sufficient to activate Trk signaling and protect neuronal cells from rotenone J. Neurochem. 124 2013 571 580